Insys Slams BCBS Privilege Claim In $19M Fentanyl Suit
Fentanyl maker Insys Therapeutics Inc. has filed a blistering request in Arizona federal court to wrest documents from Blue Cross Blue Shield over the insurer's allegations that Insys conjured up $19...To view the full article, register now.
Already a subscriber? Click here to view full article